chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pityriasis lichenoides et varioliformis acuta; Dose 2, Progressed(Multiple papules); This is a literature report for the following literature source(s):  A female patient in her 50's received BNT162b2 (BNT162B2), as dose 1. single (Batch/Lot number: unknown) and as dose 2. single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Psoriasis" (unspecified if ongoing); "transverse myelitis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA (medically significant), 14 days after the suspect product(s) administration, outcome "recovering"; CONDITION AGGRAVATED (medically significant), outcome "recovering", described as "Dose 2, Progressed(Multiple papules)". The patient underwent the following laboratory tests and procedures: CD30 expression: positive; CD4/CD8 ratio: 2:1, notes: Unknown unit; Histology: Performed; SARS-CoV-2 test: Unknown result; T-cell receptor gene rearrangement test: negative. Therapeutic measures were taken as a result of pityriasis lichenoides et varioliformis acuta, condition aggravated.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : PV202200028643 Same article/ drug and different patient/event.;US-PFIZER INC-PV202200028643 Same article/ drug and different patient/event.;
Fever; chills; severe headache; fatigue; swollen lymph nodes; sore throat; body aches; LARGE, INFLAMED, RED MASS 1-2 INCHES BELOW INJECTION SITE. Extreme and sustained pain and swelling of the arm. Hot to the touch. Tingling from jawline on left side of face to fingertips of left hand persists after 50+ hours post-injection. Swelling on arm is approximately 6 inches in diameter. The red, concentrated area is approximately 3 inches wide by 2 inches high at the center of the swelling.
After two full term pregnancies in 2018 and 2019, I had three miscarriages in six months. The only change in my life was getting the COVID-19 vaccine (Pfizer 1 and 2 and Moderna booster). Miscarriages all occurred at 5 weeks. Here are the dates: November 8, 2021 January 30, 2022 May 22, 2022
generalized malaise; arm pain; headache; earache; This is a spontaneous report from contactable consumer reported for his cousin via Representative. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced arm pain, headache, earache and generalized malaise. The outcome was unknown.  Information on the Lot/Batch number has been requested
Pt received vaccine and was fine for the 15 minutes after then developed numbness & tingling in right side of face & arm & top of hand. Lower body not affected. No treatment, BP was 103/75 & HR 83. PT had no other issues.
Achy 7hours after Chills/achy 11 hours after-ibuprofen given Headache/achy 17hours after- Tylenol given
Patients right leg swelled up from foot all the way to groin started 5-20-21 patient went to hospital 5-21-21. Also developed blisters all over the leg (front and back)
On 11/24/99, 2 days post vax, the pt presented to the clinic with a red, hot, swollen reaction at the injection site. The area was described as a 3 X 2 inch patch on her arm that appeared to have a white ring around it. The pt was treated with Diprolene cream twice daily. On 11/27/99, the pt recovered.
Patient presented to ED with nursing home report stating patient is altered compared to baseline, and less interactive than normal. History is otherwise limited by mental status. Patient was found to have UTI and COVID-19. Patient will be admitted to the hospital.
Sore arm.  No other "regular" side effects- felt fine.  However, as soon as we were driving home after the second vaccine, I noticed what felt like patches of novocaine wearing off my face.  Within two days, my toes, feet, legs, arms, fingers, face and head all had patches of tingliness/pins and needles.  I also had numbness most prominently in my toes, and a little in my fingers.  Not to the point where I couldn't feel or move my toes- just that I noticed it.  I have a history of very mild neuropathy from my pregnancy 15 years ago- on right two toes, right heel and right forefinger.  Dr. assumes it was caused by a pinched nerve from extra weight on my back.  This numbness from the vaccine was much greater, as were the pins and needles.  Just saw a neurologist today who theorizes that the mild neuropathy, coupled with the chemotherapy I received in 2014 got aggravated from my immune system getting flared up from the vaccine.  It took 7-8 weeks, but the pins and needles are completely gone, and the numbness is mostly gone (almost back to where it was originally, which is nil).  *I was diagnosed with leiomyosarcoma in March 2014, and thankfully sailed through the process with what I thought, no lasting side effects as I am active and healthy.  I am cancer free almost 7 years later, but I did take chemo from May-Oct 2014.   The neurologist  said one can get "sick nerves" from chemotherapy, and while I didn't realize it, maybe I am at 75% with my nerves, and when my immune system was reacting to the vaccine, it couldn't fight it as well as someone who hasn't had chemo, thus the reaction.    She asked me to report it.  My Internal Medicine doctor sent me to the neurologist about my pins and needles, though just got in today.
Left Leg Pain/trouble walking, still ongoing Rt. arm soreness/1 week Rt. arm itch/2 weeks
Case number PHEH2015US020969, is a combined initial and follow-up spontaneous report from a health care professional received on 16 Oct 2015. This report refers to a 23-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with intramuscular dose of FLUVIRIN (batch number: 1515601) at a dose of 1 ml instead of 0.5 ml on 14 Oct 2015. The case was assessed as non-serious. No adverse event was reported.
Pfizer vaccinated on 3/1/2021. On 4/4/2021, I suddenly found hearing loss of left ear. When listening to music with headphones, the sound in the left ear is so weak that almost no sound can be herd. I am really frightened and worried it's going to be permanent.
mom describes urticarial rash onset 12-24 hrs p/vax w/t102; ER MD dx was immun react to DTP, w/concommittant OM;
PT WAS SEEN IN ER 8 DAYS AFTER IMM W/ RASH/ REFERRED TO CLINIC NEXT DAY.  PRESUMED ALLERGIC RXN TO TYLENOL COLD RX AND WAS TREATED W/ SOLUMEDROL AND ORAL PREDNISONE AND LORATADINE. I SAW PT FIRST, 16 DAYS POST IMMUNIZATION (SMALL POX) AND HE WAS IMPROVING BUT STILL HAD PURPURA ON LEGS/NON HEMMORHAGIC/NON BLANCHING/ AND COALESCED SALMON COLORED MACULAR RASH TO REMAINDER OF BODY, THAT DOES NOT BLANCH. PT FEELING WELL, NO FURTHER TX. WILL DO CBC/UA/CHEM TODAY AND HE WILL FOLLOW UP NEXT WEEK.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 24-JUN-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) lot # L035105 expiration date 14-MAY-2017, dose and route were unspecified. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of 8.7 Fahrenheit degree (also reported as Celsius degree). The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 9 Fahrenheit degree (also reported as Celsius degree). The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Pt 1hr complains of generalized itching particularly in upper torso, no redness, no rash, occurred about 1 wk after vaccine still persists 1 month later.
Rec'd vaccine on 10.5.23.  Later that night had malaise, felt hot and significant leg cramps bilaterally.  States occasionally gets cramps but usually only in one leg,  Also states on 10/7 experienced 2 episodes where she "blacked out" momentarily. States it was a long enough episode where she hit her head on a cabinet. States had similar episodes 5 years ago and never had them checked out.
Saturday (shot at 4pm), muscle pain at injection site within minutes. Sun AM upon waking: nausea, chills, body aches, multiple rashes up to 4 inches long and 3 inches wide over torso, chest, and arms. Mon AM: nausea, chills, aches have resolved but rash has seemed to move to other areas including back. The rashes are not larger in size, just moving to different areas of the body **this patient states that any time she is fighting off a virus, like a cold, she gets these same rashes**
Adult dose of COVID19 Bivalent was given to a 10 year old child.
lost of taste; loss of smell; congestion; cough; body aches; fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion) and COUGH (cough) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PROPRANOLOL for an unknown indication.    On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Jun-2021, the patient experienced AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion), COUGH (cough), MYALGIA (body aches) and FATIGUE (fatigue). The patient was treated with GUAIFENESIN (MUCINEX) at a dose of 1 dosage form; IBUPROFEN at a dose of 1 dosage form; BENZONATATE at a dose of 1 dosage form and PROMETHAZINE at a dose of 1 dosage form. On 27-Apr-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion), COUGH (cough), MYALGIA (body aches) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jul-2021, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-253081 (Patient Link).
Slight fatigue, muscle aches, very sore arm at injection site. Symptoms started subsiding as the second day went on. I have had a normal pregnancy this far and my due date is July 19th.
He has a "dent" on his upper arm - the area where he was shot with vaccine. The skin has discoloration. The affected area is about 2 inches long. He complains about pain when he lifts an item/object.
Arm feels numb from elbow to fingers, also has had some tingly feeling in fingers.
Patient broke out in a rash. Red and itchy. Rash is on patient's back. Hurts to scratch.
Sudden onset severe itching of hands and toes , like I was being electrified by stinging insects. It was off and on for a day   Severe insomnia now for 2 days
I had been on very high dose of ibuprofen for 2 months. I stopped the ibuprofen and the next day the joint pain started. I had my next vaccine on October 14, 2022, which was Dose 5. The next day I had very bad cold symptoms. I was stuffed up and I felt pretty bad. I had a cough and was sneezing. I took an at home COVID-19 test negative. It persisted into the following week, so I went to the urgent care center and was tested for COVID-19 and Flu test, and both were negative. I was told to treat with over-the-counter medication. They indicated that it was likely a bad cold but due to the timing and joint pain I wanted to ensure I did not have something worse. For about 3 weeks I continued to feel stuffed up, my nose was running, and the joint pain continued. It was worse after I had the 5th dose of the vaccine on October 14, 2022 (Pfizer-Left Arm-Lot#GH9700). I do feel like I have recovered from all symptoms except the joint pain. I saw an orthopedist last week who think it is related to my osteoarthritis.
Received my second Pfizer shot on Thursday late afternoon. Beginning in the early hours of the morning on Monday (around 1 a.m.), developed severe itchy raised welts/rash on the entire body, from calves to neck. Lotion and hydrocortisone cream did not relieve the severe itchiness. Entire body felt heated and unbearable. Was only able to sleep in short spurts. At some point in the early morning, after 5 a.m., felt very uncomfortable and mildly nauseous and headed to the bathroom to splash some water on my face. Lost consciousness in the bathroom, unsure for how long, and came to in the tub, having clearly fallen in. Ended up falling asleep on top of bed covers, and when I awoke a few hours later, all evidence of welts/rash on my skin were gone.
suspected vaccination failure; got them again; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had 4 times).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient's cousin. The age at vaccination was not reported. The reporter got shingles 3 times.  He/she was going to get a Shingles shot but the patient who had them 4 times already got the Shingles vaccine and then got shingles again.  Then they were having side effects from the vaccine, so reporter passed on it.  The reporter stated that, medications they gave were helpful, but they took forever to clear up. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
This spontaneous report as received from a physician refers to a female. Last week, in August 2012, the patient was vaccinated with a dose of ZOSTAVAX (dose route and lot # not reported). Two days after vaccination, in August 2012 the patient got shingles. The patient experienced rash; however the rash was not at the injection site. At the time of the report the patient was recovering from the events. Additional information has been requested.
ANGIOGRAM ABNORMAL; CATHETERISATION CARDIAC; ELECTROCARDIOGRAM ABNORMAL; STENT PLACEMENT; CARDIAC DISORDER; ARTERIAL OCCLUSIVE DISEASE; CHEST DISCOMFORT; CHEST PAIN; This spontaneous report received from a patient via Regulatory Authority Agency; concerned a 60 year old male. The patient's height, and weight were not reported. The patient had no known allergies, no current illness and history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 07-APR-2021 in right arm for prophylactic vaccination. All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided. Concomitant medications included curcuma longa anti-inflammatory, multiple vitamins, naproxen sodium pain reliver and additional vitamins.  On 03-MAY-2021, A few weeks receiving the vaccination, patient started having chest pressure and pain (chest discomfort, chest pain). He was hospitalized (date unspecified) for 1 day. On 02-JUN-2021, he had severe pressure and pain in his chest. He went to the emergency room. An electrocardiogram indicated an abnormal heart problem (cardiac disorder). Angiogram revealed an artery blockage (arterial occlusive disease). A stent was inserted into the artery to resume blood flow (stent placement). Laboratory data included: Angiogram (NR: not provided) Artery blockage (Abnormal), Catheterizations cardiac (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Abnormal heart problem, and Stent placement (NR: not provided) Unknown. The action taken with covid-19 vaccine ad26.cov2. s was not applicable. The patient recovered from cardiac disorder, arterial occlusive disease, chest discomfort, chest pain, angiogram abnormal, catheterization cardiac, electrocardiogram abnormal, and stent placement. This report was serious (Hospitalization Caused / Prolonged, and Life Threatening).  Additional information was received on 28-SEP-2021. All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided.; Sender's Comments: V1: Additional information in this version updates: All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided. This updated information does not alter the causality of previously reported events. 20210751650-COVID-19 VACCINE AD26.COV2.S-Cardiac disorder, arterial occlusive disease, chest discomfort, chest pain, angiogram abnormal, catheterisation cardiac, electrocardiogram abnormal, stent placement. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Starting at about 1 pm on 11/13/2009 I had a runny nose and sneezing. That progressed to a headache and mild fever, then at about 8:00 pm I noticed hives on the left side of my neck and upper torso. The vaccine was administered in my left arm which has been sore since the vaccine was received and as of 8 pm on 11/13 is warm to the touch.
Felt like tongue was swelling within first 30 minutes of influenza shot.  Given 50 mg diphenhydramine oral solution and observed.  Felt stable.  Will go back to hotel room and sleep.  Will report to protocol physician and PCP.  Has PCP visit tomorrow anyways.
12/3/2022 About mid-day, I had a sore throat. I drank tea with honey and a shot of brandy and it did not help. In the evening I took NYQUIL when I went to bed. The next day, I had more of a sore throat that went away that evening. I was very fatigued and stayed in bed pretty much all day. It felt like I had a head cold. That night I had really strange dreams, it was very weird. On 12/5/22, I took a home COVID test and it was positive. I called my doctor's office and was prescribed PAXLOVID. I began taking it that afternoon. I took NYQUIL that night and had trouble breathing. I began having a runny nose. Around 2 in the morning, I was not having that much trouble breathing. I felt I was in a better place by 2 or 3 in the morning and was able to sleep for a while. On 12/6/22 I worked from home. That night, I slept better, but in the middle of the night I woke with real pain in the joints in my elbows. It felt like the worse arthritis. The next morning, they were still tender, but the pain had passed. 12/7/22, I was coughing, congestion and a runny nose with thick green mucous. By 12/8/22 I was feeling better and was a lot better by 12/9/22. 12/11/22 I took a home COVID test and it was negative. I was still coughing a little with thick mucous. I spoke to my doctor again and he put me on antibiotics which I have been taking and am now symptom free.
2/4/2023 woke up with sore throat and cough.  This progressed all day and during the evening I developed sever chills, body aches, shortness of breath in addition to cough and sore throat.  Increased heart rate to 75 during sleep.  2/5/2023 Tested Positive on At Home COVID-19 test and had a televisit with doctor.  Doctor prescribed Paxlovid.  Symptoms decreased upon starting Paxlovid.  On the 7th, there was just increased heart rate, and a little shortness of breath. 2/15 symptoms returned for just one day, chills and increased heart rate.
chills; swelling of the arm in which the dose was administered; a rash/It is unknown where on the patient's body the rash was located.; This initial spontaneous report was received from a physician via a company representative referring to a 79 years old female patient. Information about concomitant medications, pertinent medical history, drug reactions or allergies was unknown by the reporter.      On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (lot # S021740, expiration date 25-MAR-2021; dosage detail, strength and route were not reported) for prophylaxis.    On an unknown date, the patient experienced chills, swelling of the arm in which the dose was administered and a rash. It was unknown where on the patient's body the rash was located. The patient was hospitalized in an unspecified hospital on an unspecified date after administration of the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23). The patient had sought medical attention and had treatment given for the events. It was unknown if any laboratory tests were performed for the events. The outcome of the events was unknown. Causality assessment was not provided. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: S021740; expirationdate: 25-MAR-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: No; reasonfornoneval: 81 Other; reasonfornonevalother: No information about the availability; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2003USA003005: